Shelby Derene Reed, PhD

Professor in Population Health Sciences
Professor in Medicine
Associate of the Duke Initiative for Science & Society
Member in the Duke Clinical Research Institute
Member of the Duke Cancer Institute
Campus mail Duke Box 17969, #6044 North Pavilion, Durham, NC 27715
Phone (919) 668-8991
Email address shelby.reed@duke.edu

Shelby D. Reed, PhD, is a professor in medicine at the Duke University School of Medicine. She works primarily at the Duke Clinical Research Institute. Dr. Reed holds a PhD in pharmaceutical health services research from the University of Maryland School of Pharmacy and completed a 2-year postdoctoral fellowship in the Pharmaceutical Outcomes Research and Policy Program and the Center for AIDS Research at the University of Washington. Dr. Reed has nearly 20 years of experience in economic evaluation, health services research and health policy. Dr. Reed has extensive expertise in designing and conducting trial-based and model-based cost-effectiveness analyses of medical diagnostics and interventions in numerous therapeutic areas. She was a member of the ISPOR Task Forces that published recommendations for Good Research Practices for Cost-Effectiveness Analysis Alongside Clinical Trials in 2005 and 2015. She has led a wide range of economic and epidemiological studies using secondary data from health care claims, clinical trials, surveys and disease registries. In her evaluations of health policy issues, she has developed computer models to analyze the potential economic impact of trends in clinical trial design, changes in reimbursement policies, financial incentives and the regulatory process in the development of orphan drugs, and the societal value of alternative approaches to identifying drug safety problems. 

Areas of expertise: Health Economics, Health Measurement, Health Policy, and Health Services Research

Education and Training

  • Ph.D., University of Maryland, College Park, 1998

Publications

Levitan, B. S., E. G. Katz, R. L. DiSantostefano, J. C. Yang, A. O. Fairchild, S. D. Reed, and F. R. Johnson. “Beating the Benchmarks: Using Patient Preferences to Increase the Probability of Development Success.” In Patient Patient Centered Outcomes Research, 12:431–431. ADIS INT LTD, 2019.

Scholars@Duke

Hung, A., Y. Li, F. J. Keefe, D. C. Ang, J. Slover, R. A. Perera, L. Dumenci, S. D. Reed, and D. L. Riddle. “Ninety-day and one-year healthcare utilization and costs after knee arthroplasty..” Osteoarthritis Cartilage, June 6, 2019. https://doi.org/10.1016/j.joca.2019.05.019.

PMID
31176805
Full Text

Bethel, M Angelyn, Rishi A. Patel, Vivian P. Thompson, Peter Merrill, Shelby D. Reed, Yanhong Li, Sara Ahmadi, et al. “Changes in Serum Calcitonin Concentrations, Incidence of Medullary Thyroid Carcinoma, and Impact of Routine Calcitonin Concentration Monitoring in the EXenatide Study of Cardiovascular Event Lowering (EXSCEL)..” Diabetes Care 42, no. 6 (June 2019): 1075–80. https://doi.org/10.2337/dc18-2028.

PMID
31010875
Full Text

Johnson, F Reed, Frank I. Scott, Shelby D. Reed, James D. Lewis, and Meenakshi Bewtra. “Comparing the Noncomparable: The Need for Equivalence Measures That Make Sense in Health-Economic Evaluations..” Value Health 22, no. 6 (June 2019): 684–92. https://doi.org/10.1016/j.jval.2019.03.011.

PMID
31198186
Full Text

Reed, Shelby D., Robert W. Dubois, F Reed Johnson, J Jaime Caro, and Charles E. Phelps. “Novel Approaches to Value Assessment Beyond the Cost-Effectiveness Framework..” Value Health 22, no. 6S (June 2019): S18–23. https://doi.org/10.1016/j.jval.2019.04.1914.

PMID
31200802
Full Text

Bewtra, Meenakshi, Shelby D. Reed, F Reed Johnson, Frank I. Scott, Erin Gilroy, Robert S. Sandler, Wenli Chen, and James D. Lewis. “Variation Among Patients With Crohn's Disease in Benefit vs Risk Preferences and Remission Time Equivalents..” Clin Gastroenterol Hepatol, May 14, 2019. https://doi.org/10.1016/j.cgh.2019.05.010.

PMID
31100456
Full Text

Scott, Frank I., F Reed Johnson, Meenakshi Bewtra, Colleen M. Brensinger, Jason A. Roy, Shelby D. Reed, Mark T. Osterman, et al. “Improved Quality of Life With Anti-TNF Therapy Compared With Continued Corticosteroid Utilization in Crohn's Disease..” Inflamm Bowel Dis 25, no. 5 (April 11, 2019): 925–36. https://doi.org/10.1093/ibd/izy321.

PMID
30535149
Full Text

Dinan, Michaela A., Lauren E. Wilson, and Shelby D. Reed. “Chemotherapy Costs and 21-Gene Recurrence Score Genomic Testing Among Medicare Beneficiaries With Early-Stage Breast Cancer, 2005 to 2011..” J Natl Compr Canc Netw 17, no. 3 (March 1, 2019): 245–54. https://doi.org/10.6004/jnccn.2018.7097.

PMID
30865923
Full Text

Shaw, Ryan, Erica Levine, Martin Streicher, Elizabeth Strawbridge, Jennifer Gierisch, Jane Pendergast, Sarah Hale, et al. “Log2Lose: Development and Lessons Learned From a Mobile Technology Weight Loss Intervention..” Jmir Mhealth Uhealth 7, no. 2 (February 13, 2019). https://doi.org/10.2196/11972.

PMID
30758297
Full Text

Pages